Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation

  1. Molina-Cerrillo, J.
  2. Alonso-Gordoa, T.
  3. Carrato, A.
  4. Grande, E.
Revue:
Oncotarget

ISSN: 1949-2553

Année de publication: 2020

Volumen: 11

Número: 22

Pages: 2137-2140

Type: Article

DOI: 10.18632/ONCOTARGET.27598 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable